Betsson AB - BETS-B.ST

BETS-B.ST Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
BETS-B.ST	0.0	2.9	1.7	4.6	22.6	37.6	231.4	321.0	100.8	282.6
S&P 500	0.5	2.1	1.3	5.3	12.7	25.7	38.7	85.7	197.4	34547.3

Compare BETS-B.ST with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	BETS-B.ST
name	Betsson AB
price	145.4
changes percentage	0.0413
change	0.06
day low	144.84
day high	146.3
year high	147.62
year low	99.1
market cap	22077659735
price avg 50	142.3724
price avg 200	130.1024
exchange	STO
volume	37897
avg volume	286698
open	145.34
previous close	145.34
eps	14.2
pe	10.24
earnings announcement	2025-02-06T06:30:00.000+0000
shares outstanding	151840851
timestamp	2025-01-24 13:16:14

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 68.3%

Overall Quarterly Financial Health: 37.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	948200000	777200000	22.00
gross profit	756333000	504363000	49.96
gross profit ratio	0.8	0.65	22.91
research and development expenses	25200000	23500000	7.23
operating expenses	545833000	371213000	47.04
interest income	4523000	1283000	252.53
interest expense	12817000	7266000	76.40
ebitda	259785000	173079000	50.10
ebitdaratio	0.27	0.22	25.33
operating income	210500000	131200000	60.44
operating income ratio	0.22	0.17	31.51
net income	177300000	119600000	48.24
net income ratio	0.19	0.15	21.51
eps	1.29	0.87	48.28

Overall Score of Annual Income Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 948 million in 2023 from 777 million in 2022 representing a change of 22.0%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 756 million in 2023 from 504 million in 2022 representing a change of 49.96%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 25 million in 2023 from 24 million in 2022 representing a change of 7.23%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 260 million in 2023 from 173 million in 2022 representing a change of 50.1%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 210 million in 2023 from 131 million in 2022 representing a change of 60.44%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 177 million in 2023 from 120 million in 2022 representing a change of 48.24%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 1.29 in 2023 from 1.29 in 2022 representing a change of 48.28%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 546 million in 2023 from 371 million in 2022 representing a change of 47.04%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
revenue	280100000	271500000	3.17
gross profit	223400000	176800000	26.36
gross profit ratio	0.8	0.65	22.48
research and development expenses	13800000	6700000	105.97
operating expenses	158900000	112700000	40.99
interest income	0	6900000	-100.00
interest expense	0	13800000	-100.00
ebitda	95700000	77700000	23.17
ebitdaratio	0.34	0.29	19.38
operating income	64500000	64100000	0.62
operating income ratio	0.23	0.24	-2.47
net income	42900000	45500000	-5.71
net income ratio	0.15	0.17	-8.61
eps	0.31	0.33	-6.06

Overall Score of Quarterly Income Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 280 million in 2024Q3 from 272 million in 2024Q2 representing a change of 3.17%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 223 million in 2024Q3 from 177 million in 2024Q2 representing a change of 26.36%. This indicates a sales profitability growth, which is a positive sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 96 million in 2024Q3 from 78 million in 2024Q2 representing a change of 23.17%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 64 million in 2024Q3 from 64 million in 2024Q2 representing a change of 0.62%. The increase in operating income indicates better operational performance and increased profitability.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 14 million in 2024Q3 from 7 million in 2024Q2 representing a change of 105.97%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 159 million in 2024Q3 from 113 million in 2024Q2 representing a change of 40.99%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Net Income: Net income decreased to 43 million in 2024Q3 from 46 million in 2024Q2 representing a change of -5.71%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.31 in 2024Q3 from 0.31 in 2024Q2 representing a change of -6.06%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	1200100000	1018700000	17.81
total liabilities	440900000	370900000	18.87
total equity	759200000	647800000	17.20
cash and cash equivalents	237100000	168300000	40.88
short term investments	-35000	-32000	-9.38
long term investments	16900000	19600000	-13.78
total current assets	434600000	368600000	17.91
total non current assets	765500000	650100000	17.75
total current liabilities	254200000	258800000	-1.78
total non current liabilities	186700000	112100000	66.55
common stock	9400000	9400000	0.00
retained earnings	592400000	471600000	25.61
total debt	184200000	115000000	60.17

Overall Score of Annual Balance Sheet

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 1,200 million in 2023 from 1,019 million in 2022 representing a change of 17.81%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 759 million in 2023 from 648 million in 2022 representing a change of 17.2%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 237 million in 2023 from 168 million in 2022 representing a change of 40.88%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 435 million in 2023 from 369 million in 2022 representing a change of 17.91%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 254 million in 2023 from 259 million in 2022 representing a change of -1.78%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 592 million in 2023 from 472 million in 2022 representing a change of 25.61%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 441 million in 2023 from 371 million in 2022 representing a change of 18.87%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 0 million in 2023 from 0 million in 2022 representing a change of -9.38%. This indicates a decrease in short-term investment holdings.

  Total Debt: Total Debt increased to 184 million in 2023 from 115 million in 2022 representing a change of 60.17%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
total assets	1386900000	1312900000	5.64
total liabilities	586600000	511800000	14.62
total equity	800300000	801100000	-0.10
cash and cash equivalents	337500000	263900000	27.89
short term investments	0	0	NaN
long term investments	22800000	21200000	7.55
total current assets	619300000	547300000	13.16
total non current assets	767600000	765700000	0.25
total current liabilities	360400000	322200000	11.86
total non current liabilities	226200000	189600000	19.30
common stock	0	814100000	-100.00
retained earnings	0	0	NaN
total debt	225200000	184100000	22.32

Overall Score of Quarterly Balance Sheet

0.38 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 1,387 million in 2024Q3 from 1,313 million in 2024Q2 representing a change of 5.64%. Suggesting a growth in asset holdings.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 338 million in 2024Q3 from 264 million in 2024Q2 representing a change of 27.89%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 619 million in 2024Q3 from 547 million in 2024Q2 representing a change of 13.16%. This indicates a better liquidity position.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 587 million in 2024Q3 from 512 million in 2024Q2 representing a change of 14.62%. This indicates an increase in overall liabilities.

  Total Equity: Total Equity decreased to 800 million in 2024Q3 from 801 million in 2024Q2 representing a change of -0.1%. This indicates a decrease in shareholders' equity.

  Total Current Liabilities: Total Current Liabilities increased to 360 million in 2024Q3 from 322 million in 2024Q2 representing a change of 11.86%. This indicates a higher short-term debt burden.

  Common Stock: Common Stock decreased to 0 in 2024Q3 from 814 in 2024Q2 representing a change of -100.0%. This indicates a decrease in ownership interest.

  Total Debt: Total Debt increased to 225 million in 2024Q3 from 184 million in 2024Q2 representing a change of 22.32%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	68800000	72700000	-5.36
operating cash flow	230400000	178700000	28.93
free cash flow	189000000	143200000	31.98
capital expenditure	-41400000	-35500000	-16.62
depreciation and amortization	52168000	41213000	26.58
deferred income tax	0	0	NaN
stock based compensation	1600000	300000	433.33
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	-117600000	-7500000	-1468.00
investments in property plant and equipment	-3400000	-35500000	90.42
net cash used for investing activites	-159000000	-51200000	-210.55
debt repayment	65300000	-2000000	3365.00
common stock issued	900000	1900000	-52.63
common stock repurchased	-59700000	-50300000	-18.69
dividends paid	0	0	NaN
net cash used provided by financing activities	300000	-54700000	100.55
cash at end of period	237100000	168300000	40.88
accounts receivables	-16399999	-21600000	24.07
cash at beginning of period	168300000	95600000	76.05

Overall Score of Annual Cashflow Statement

0.5 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to 69 million in 2023 from 73 million in 2022 representing a change of -5.36%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Stock-Based Compensation: Stock-Based Compensation increased to 2 million in 2023 from 0 million in 2022 representing a change of 433.33%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Receivables: Accounts Receivables increased to -16 in 2023 from -22 million in 2022 representing a change of 24.07%. This suggests that the company is less capable of collecting payments from its customers.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 230 million in 2023 from 179 million in 2022 representing a change of 28.93%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 189 million in 2023 from 143 million in 2022 representing a change of 31.98%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -41 million in 2023 from -36 million in 2022 representing a change of -16.62%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
operating cash flow	62500000	75800000	-17.55
free cash flow	51200000	64300000	-20.37
capital expenditure	-11300000	-11500000	1.74
depreciation and amortization	0	6900000	-100.00
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	0	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	-11900000	-2600000	-357.69
investments in property plant and equipment	-11300000	-11500000	1.74
net cash used for investing activites	-23100000	-14100000	-63.83
debt repayment	39900000	-800000	5087.50
common stock issued	-1600000	0	NaN
common stock repurchased	0	-46000000	100.00
dividends paid	0	0	NaN
net cash used provided by financing activities	35000000	-36400000	196.15
net change in cash	73600000	24600000	199.19
cash at end of period	337500000	263900000	27.89
cash at beginning of period	263899999	239300000	10.28

Overall Score of Quarterly Cashflow Statement

0.25 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 74 million in 2024Q3 from 25 million in 2024Q2 representing a change of 199.19%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 62 million in 2024Q3 from 76 million in 2024Q2 representing a change of -17.55%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 51 million in 2024Q3 from 64 million in 2024Q2 representing a change of -20.37%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -11 million in 2024Q3 from -12 million in 2024Q2 representing a change of 1.74%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	6.9	5.65	22.03
net income per share	1.29	0.87	48.28
operating cash flow per share	1.68	1.3	28.96
free cash flow per share	1.38	1.04	32.01
cash per share	1.72	1.22	40.92
book value per share	5.52	4.71	17.22
tangible book value per share	0.31	0.38	-18.52
shareholders equity per share	5.6	4.76	17.73
interest debt per share	1.43	0.89	61.17
market cap	1258309146.07	958646951.37	31.26
enterprise value	1205409146.07	905346951.37	33.14
pe ratio	7.1	8.02	-11.46
price to sales ratio	1.33	1.23	7.59
pocfratio	5.46	5.36	1.81
pfcf ratio	6.66	6.69	-0.55
pb ratio	1.63	1.47	11.52
ptb ratio	1.63	1.47	11.52
ev to sales	1.27	1.16	9.13
enterprise value over ebitda	4.64	5.23	-11.29
ev to operating cash flow	5.23	5.07	3.27
ev to free cash flow	6.38	6.32	0.88
earnings yield	0.14	0.12	12.94
free cash flow yield	0.15	0.15	0.55
debt to equity	0.24	0.18	36.09
debt to assets	0.15	0.11	35.96
net debt to ebitda	-0.2	-0.31	33.88
current ratio	1.71	1.42	20.04
interest coverage	16.42	18.06	-9.04
income quality	1.18	1.43	-17.53
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.28	0.14	105.76
research and ddevelopement to revenue	0.03	0.03	-12.10
intangibles to total assets	0.6	0.59	2.11
capex to operating cash flow	0.18	0.2	-9.55
capex to revenue	0.04	0.05	-4.41
capex to depreciation	0.79	0.86	-7.87
stock based compensation to revenue	0.0	0.0	337.15
graham number	12.75	9.65	32.12
roic	0.2	0.2	-2.26
return on tangible assets	0.37	0.28	29.69
graham net net	-1.22	-1.16	-4.82
working capital	180400000	109800000	64.30
tangible asset value	42018000	51581000	-18.54
net current asset value	-6300000	-2300000	-173.91
invested capital	919473000	732170000	25.58
average receivables	52500500	58039000	-9.54
average payables	16500000	15800000	4.43
average inventory	0	58344500	-100.00
days sales outstanding	18.55	26.68	-30.50
days payables outstanding	28.92	23.81	21.43
days of inventory on hand	0	0	NaN
receivables turnover	19.68	13.68	43.88
payables turnover	12.62	15.33	-17.65
inventory turnover	0	0	NaN
roe	0.23	0.18	25.95
capex per share	0.3	0.26	16.64

• Positive

  ROE: Return on Equity (ROE) increased to 0.23 on 2023-12-31 from 0.18 on 2022-12-31, representing a change of 25.95%. Suggesting the company has been generating high returns for its shareholders.

  Current Ratio: Current Ratio increased to 1.71 on 2023-12-31 from 1.42 on 2022-12-31, representing a change of 20.04%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 7.10 on 2023-12-31 from 8.02 on 2022-12-31, representing a change of -11.46%. Indicating a decrease in the relative valuation of the company's stock.

• Neutral

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.24 on 2023-12-31 from 0.18 on 2022-12-31, representing a change of 36.09%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
BETS-B.ST
calendar year	2024	2024	NaN
revenue per share	2.02	1.97	2.79
net income per share	0.31	0.33	-6.06
operating cash flow per share	0.45	0.55	-17.85
free cash flow per share	0.37	0.47	-20.67
cash per share	2.44	1.91	27.42
book value per share	5.78	5.81	-0.47
tangible book value per share	0.6	0.63	-4.40
shareholders equity per share	5.88	5.9	-0.44
interest debt per share	1.63	1.44	13.38
market cap	1517386830.22	1491059477.77	1.77
enterprise value	1405086830.22	1411259477.77	-0.44
pe ratio	8.84	8.19	7.93
price to sales ratio	5.42	5.49	-1.36
pocfratio	24.28	19.67	23.42
pfcf ratio	29.64	23.19	27.80
pb ratio	1.87	1.83	1.84
ptb ratio	1.87	1.83	1.84
ev to sales	5.02	5.2	-3.49
enterprise value over ebitda	14.68	18.16	-19.16
ev to operating cash flow	22.48	18.62	20.75
ev to free cash flow	27.44	21.95	25.04
earnings yield	0.03	0.03	-7.35
free cash flow yield	0.03	0.04	-21.75
debt to equity	0.28	0.23	22.42
debt to assets	0.16	0.14	15.80
net debt to ebitda	-1.17	-1.03	-14.26
current ratio	1.72	1.7	1.16
interest coverage	0	4.64	-100.00
income quality	1.1	1.33	-16.82
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.26	0.27	-5.05
research and ddevelopement to revenue	0.05	0.02	99.65
intangibles to total assets	0.52	0.54	-4.98
capex to operating cash flow	0.18	0.15	19.17
capex to revenue	0.04	0.04	-4.76
capex to depreciation	0	1.67	-100.00
stock based compensation to revenue	0	0	NaN
graham number	6.4	6.62	-3.29
roic	0.05	0.05	-4.46
return on tangible assets	0.06	0.08	-15.76
graham net net	-0.27	-1.8	84.83
working capital	258900000	225100000	15.02
tangible asset value	82900000	86400000	-4.05
net current asset value	32700000	35500000	-7.89
invested capital	995500000	960300000	3.67
average receivables	140900000	134300000	4.91
average payables	0	0	NaN
average inventory	0.5	0.5	-0.00
days sales outstanding	90.55	0	NaN
days payables outstanding	0	0	NaN
days of inventory on hand	0	0.0	-100.00
receivables turnover	0.99	0	NaN
payables turnover	0	0	NaN
inventory turnover	0	94700000	-100.00
roe	0.05	0.06	-5.64
capex per share	0.08	0.08	-2.10

• Negative

  ROE: Return on Equity (ROE) decreased to 0.05 on 2024-09-30 Q3 from 0.06 on 2024-06-30 Q2, representing a change of -5.64%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 8.84 on 2024-09-30 Q3 from 8.19 on 2024-06-30 Q2, representing a change of 7.93%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 1.72 on 2024-09-30 Q3 from 1.70 on 2024-06-30 Q2, representing a change of 1.16%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

• Neutral

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.28 on 2024-09-30 Q3 from 0.23 on 2024-06-30 Q2, representing a change of 22.42%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None